DK0437687T3 - Fremgangsmåde til rensning af et 69.000 dalton-antigenisk protein fra Bordetella tertussis - Google Patents

Fremgangsmåde til rensning af et 69.000 dalton-antigenisk protein fra Bordetella tertussis

Info

Publication number
DK0437687T3
DK0437687T3 DK90120662.3T DK90120662T DK0437687T3 DK 0437687 T3 DK0437687 T3 DK 0437687T3 DK 90120662 T DK90120662 T DK 90120662T DK 0437687 T3 DK0437687 T3 DK 0437687T3
Authority
DK
Denmark
Prior art keywords
purifying
bordetella
tertussis
dalton
antigenic protein
Prior art date
Application number
DK90120662.3T
Other languages
Danish (da)
English (en)
Inventor
John William Gotto
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DK0437687T3 publication Critical patent/DK0437687T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK90120662.3T 1989-12-11 1990-10-29 Fremgangsmåde til rensning af et 69.000 dalton-antigenisk protein fra Bordetella tertussis DK0437687T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/448,777 US5276142A (en) 1989-12-11 1989-12-11 Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis

Publications (1)

Publication Number Publication Date
DK0437687T3 true DK0437687T3 (da) 1996-06-03

Family

ID=23781640

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90120662.3T DK0437687T3 (da) 1989-12-11 1990-10-29 Fremgangsmåde til rensning af et 69.000 dalton-antigenisk protein fra Bordetella tertussis

Country Status (13)

Country Link
US (1) US5276142A (fr)
EP (1) EP0437687B1 (fr)
JP (1) JP2950970B2 (fr)
KR (1) KR0180527B1 (fr)
AT (1) ATE137976T1 (fr)
AU (1) AU641711B2 (fr)
CA (1) CA2031763A1 (fr)
DE (1) DE69027013T2 (fr)
DK (1) DK0437687T3 (fr)
ES (1) ES2087109T3 (fr)
FI (1) FI101380B1 (fr)
NO (1) NO301717B1 (fr)
SG (1) SG54177A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412207D0 (en) 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
GB8910570D0 (en) * 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
US6197548B1 (en) 1990-04-02 2001-03-06 Medeva Pharma Limited Transformed Pichia expressing the pertactin antigen
GB9007657D0 (en) * 1990-04-04 1990-05-30 Connaught Lab Purification of a pertussis outer membrane protein(omp69)
EP0484621A3 (en) * 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
US6444211B2 (en) 1991-04-03 2002-09-03 Connaught Laboratories, Inc. Purification of a pertussis outer membrane protein
GB9304399D0 (en) * 1993-03-04 1993-04-21 Smithkline Beecham Biolog Novel process
KR100266556B1 (ko) * 1994-04-28 2000-09-15 다께다구니오 백일해균의 방어성분의 분리방법
DE19512346C1 (de) * 1995-04-01 1996-06-13 Behringwerke Ag Verfahren zur Reinigung von Filamenthämagglutinin und Pertussis-Toxin
ATE496634T1 (de) 1995-05-04 2011-02-15 Sanofi Pasteur Ltd Azelluläre pertussis-impfstoffe und verfahren zu deren herstellung
US5877298A (en) * 1995-05-04 1999-03-02 Connaught Lab Acellular pertussis vaccines and methods of preparing thereof
GB9611501D0 (en) * 1996-06-03 1996-08-07 Smithkline Beecham Biolog Vaccine compositions
DE69736709T2 (de) 1996-07-02 2007-10-04 Sanofi Pasteur Ltd., Toronto Vielwertige dtp-polio-impfstoffe
EP2430040A1 (fr) * 2009-05-11 2012-03-21 Novartis AG Procédé de purification d'antigène pour un antigène de pertactine
CN102584958A (zh) * 2012-02-08 2012-07-18 北京天坛生物制品股份有限公司 百日咳杆菌69kd外膜蛋白的纯化方法
WO2014135651A1 (fr) 2013-03-08 2014-09-12 Crucell Holland B.V. Vaccin acellulaire contre la coqueluche

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220717A (en) * 1977-12-22 1980-09-02 American Cyanamid Company Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
GB8512972D0 (en) * 1985-05-22 1985-06-26 Univ Glasgow Vaccine production
DE3886332T2 (de) * 1987-09-28 1994-03-31 Beecham Inc Inaktivierung von Viren und Bakterien.
US5101014A (en) * 1989-02-10 1992-03-31 United States Of America Process for the purification of a 69,000 da outer membrane protein of Bordetella pertussis

Also Published As

Publication number Publication date
AU641711B2 (en) 1993-09-30
JP2950970B2 (ja) 1999-09-20
FI906071L (fi) 1991-06-12
NO905324D0 (no) 1990-12-10
NO905324L (no) 1991-06-12
NO301717B1 (no) 1997-12-01
SG54177A1 (en) 1998-11-16
DE69027013T2 (de) 1996-12-19
FI101380B (fi) 1998-06-15
FI906071A0 (fi) 1990-12-10
EP0437687A2 (fr) 1991-07-24
EP0437687B1 (fr) 1996-05-15
EP0437687A3 (en) 1991-07-31
KR0180527B1 (ko) 1999-04-01
FI101380B1 (fi) 1998-06-15
KR910012234A (ko) 1991-08-07
US5276142A (en) 1994-01-04
JPH03191789A (ja) 1991-08-21
AU6793390A (en) 1991-06-13
ES2087109T3 (es) 1996-07-16
CA2031763A1 (fr) 1991-06-12
ATE137976T1 (de) 1996-06-15
DE69027013D1 (de) 1996-06-20

Similar Documents

Publication Publication Date Title
DK0437687T3 (da) Fremgangsmåde til rensning af et 69.000 dalton-antigenisk protein fra Bordetella tertussis
DE3561472D1 (en) Process for the extraction of poly-beta-hydroxybutyrates with a solvent from an aqueous suspension of microorganisms
FI901646A0 (fi) Kiteinen 2-O- -D-glukopyranosyyli-L-askorbiinihappo ja menetelmä sen valmistamiseksi
FI884162A7 (fi) Metod och apparat foer granulering och granulerad produkt.
FI875424A0 (fi) Tryck underkastad flotationsmodul och ett foerfarande foer tryck underkastad skumseparering.
FR2630438B1 (fr) Nouvelles p-phenylenediamines, leur procede de preparation, composition tinctoriale les contenant et procede de teinture correspondant
EP0029063A4 (fr) Procede de detection de l'antigene associe de l'hepatite non-a, non-b.
DE3769648D1 (de) Verfahren zur herstellung von kohlenstoffmolekularsieben.
DK0522291T3 (da) Fremgangsmåde til rensning af hepatitis A-virus (HAV), således renset virus og vaccinepræparater indeholdende dette
DK0646594T3 (da) Fremgangsmåde til rensning af proteiner
DK0414515T3 (da) Indretning og fremgangsmåde til vask af blod og fjernelse af plasma i flere trin
PT95789A (pt) Metodo para isolamento e purificacao de factores antigenicos da bordetella pertussis
FI873083L (fi) Foerfarande foer odling av bordetella pertussis, kikhostatoxoid och kikhostavaccin.
ES2076436T3 (es) Procedimiento de recuperacion de teicoplanina.
GR3018440T3 (en) Novel vaccine and method therefor.
DZ1687A1 (fr) Procédé d'extraction par membrane.
FR2658187B1 (fr) Nouveaux acides alpha-hydroxyles, procede de preparation et leur utilisation.
FR2597344B1 (fr) Perfectionnement au procede de purification d'antigenes proteiques de bacteries appartenant au genre bordetella, en vue de l'obtention d'un vaccin acellulaire.
FI893512L (fi) Bordetella pertussis-vaccin.
DK148489D0 (da) Fremgangsmaade til fremstilling af natriumflouralkoholater
FR2620726B1 (fr) Procede de preparation d'un extrait de jasmin et extrait obtenu
ATE123001T1 (de) Verfahren zur abtrennung von yttrium.
DK412389D0 (da) Fremgangsmaade til udvinding af oprenset epi protein fra en fermenteringsoploesning
MA21523A1 (fr) Nouveaux procedes d'extraction et de la purification de la diosmine rhamnglucosyl-7 diosmetine,hteroside flavonique elabore par les vegetaux chlorophylliens .
DE69128095D1 (de) Azelluläre impfstoffe